Notably, the same authors found that ALDH1 upregulation in the HER2+ BCSC compartment of luminal BC was attenuated by HER2 inhibition via specific small interfering RNA (siRNA) or trastuzumab treatment [56]. Here, ERBB2 is linked to breast cancer.